Professional
Added to YB: 2025-02-17
Pitch date: 2025-02-06
RVTY [bullish]
Revvity, Inc.
-15.39%
current return
Author Info
No bio for this author
Company Info
Revvity, Inc. provides health sciences solutions, technologies, and services. The company provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services; and instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Market Cap
$10.5B
Pitch Price
$118.78
Price Target
N/A
Dividend
0.30%
EV/EBITDA
15.05
P/E
47.57
EV/Sales
4.60
Sector
Life Sciences Tools and Services
Category
turnaround
Bretton Fund Portfolio Holding: Revvity, Inc.
RVTY: Ex-PerkinElmer pivots post-Covid. Now focused on reagents (75k products) & immunodiagnostics. Smaller units: lab software & newborn screening. Healthcare industry hangover after Covid windfall. 2.4% gain last year, trades at 23x earnings. Simplified portfolio after acquisitions & disposals.
Read full article (1 min)